메뉴 건너뛰기




Volumn 2, Issue 3, 2000, Pages 71-79

Anxiety and depression: Optimizing treatments

Author keywords

[No Author keywords available]

Indexed keywords


EID: 21244496258     PISSN: 15235998     EISSN: None     Source Type: Journal    
DOI: 10.4088/pcc.v02n0301     Document Type: Article
Times cited : (71)

References (71)
  • 1
    • 0031836107 scopus 로고    scopus 로고
    • Health economics and cost implications of anxiety and other mental disorders in the United States
    • Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry 1998; 173 (suppl 34):4-9
    • (1998) Br J Psychiatry , vol.173 , Issue.34 SUPPL. , pp. 4-9
    • Rice, D.P.1    Miller, L.S.2
  • 2
    • 0032799662 scopus 로고    scopus 로고
    • The economic burden of anx- Iety disorders in the 1990s
    • Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anx- iety disorders in the 1990s. J Clin Psychiatry 1999;60:427-435
    • (1999) J Clin Psychiatry , vol.60 , pp. 427-435
    • Greenberg, P.E.1    Sisitsky, T.2    Kessler, R.C.3
  • 3
    • 0028114056 scopus 로고
    • Cost of anxiety disorders: Impact of comorbidity
    • Souetre E, Lozet H, Cimarosti I, et al. Cost of anxiety disorders: impact of comorbidity. J Psychosom Res 1994;38(suppl 1):151-160
    • (1994) J Psychosom Res , vol.38 , Issue.1 SUPPL. , pp. 151-160
    • Souetre, E.1    Lozet, H.2    Cimarosti, I.3
  • 4
    • 0030050976 scopus 로고    scopus 로고
    • Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey
    • Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry 1996;168(suppl 30):17-30
    • (1996) Br J Psychiatry , vol.168 , Issue.30 SUPPL. , pp. 17-30
    • Kessler, R.C.1    Nelson, C.B.2    McGonagle, K.A.3
  • 5
    • 0028156958 scopus 로고
    • Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
    • Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19
    • (1994) Arch Gen Psychiatry , vol.51 , pp. 8-19
    • Kessler, R.C.1    McGonagle, K.A.2    Zhao, S.3
  • 7
    • 52549115724 scopus 로고
    • Anxiety algorithm
    • Primary Care Version. Washington, DC: American Psychiatric Association
    • American Psychiatric Association. Anxiety algorithm. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Primary Care Version. Washington, DC: American Psychiatric Association; 1995:47-63
    • (1995) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition , pp. 47-63
  • 8
    • 0027213217 scopus 로고
    • Use of benzodiazepines in anxiety disorders
    • Shader RI, Greenblatt DJ. Use of benzodiazepines in anxiety disorders. NEnglJMed 1993;328:1398-1405
    • (1993) NEnglJMed , vol.328 , pp. 1398-1405
    • Shader, R.I.1    Greenblatt, D.J.2
  • 10
    • 0028898694 scopus 로고
    • Diagnostic dilemmas presented by patients with anxiety and depression
    • Goldberg RJ. Diagnostic dilemmas presented by patients with anxiety and depression. Am J Med 1995;98:278-284
    • (1995) Am J Med , vol.98 , pp. 278-284
    • Goldberg, R.J.1
  • 11
    • 0023886671 scopus 로고
    • Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial, 1: efficacy in shortterm treatment
    • Ballenger JC, Burrows GD, DuPont RLJ, et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, 1: efficacy in shortterm treatment. Arch Gen Psychiatry 1988;45:413-422
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 413-422
    • Ballenger, J.C.1    Burrows, G.D.2    Dupont, R.L.J.3
  • 12
    • 0003167251 scopus 로고
    • The uses of buspirone in psychiatry
    • Sussman N. The uses of buspirone in psychiatry. J Clin Psychiatry Monograph 1994;12(1):3-19
    • (1994) J Clin Psychiatry Monograph , vol.12 , Issue.1 , pp. 3-19
    • Sussman, N.1
  • 13
    • 52549129916 scopus 로고    scopus 로고
    • Treatment of panic disorder with serotonin reuptake inhibitors (SSRIs)
    • den Boer JA, Montgomery SA, eds. Chichester, NY: JohnWiley & Sons;
    • Ballenger J. Treatment of panic disorder with serotonin reuptake inhibitors (SSRIs). In: den Boer JA, Montgomery SA, eds. SSRIs in Depression and Anxiety. Chichester, NY: JohnWiley & Sons; 1998:115-134
    • (1998) SSRIs in Depression and Anxiety , pp. 115-134
    • Ballenger, J.1
  • 14
    • 0029094582 scopus 로고
    • Sertraline for social phobia: A double-blind, placebo-controlled crossover study
    • Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152:1368-1371
    • (1995) Am J Psychiatry , vol.152 , pp. 1368-1371
    • Katzelnick, D.J.1    Kobak, K.A.2    Greist, J.H.3
  • 15
    • 0032569245 scopus 로고    scopus 로고
    • Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial
    • Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.JAMA 1998;280:708-713
    • (1998) JAMA , vol.280 , pp. 708-713
    • Stein, M.B.1    Liebowitz, M.R.2    Lydiard, R.B.3
  • 16
    • 0031984862 scopus 로고    scopus 로고
    • Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder
    • Ballenger JC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998;155:36-42
    • (1998) Am J Psychiatry , vol.155 , pp. 36-42
    • Ballenger, J.C.1    Wheadon, D.E.2    Steiner, M.3
  • 17
    • 0032751401 scopus 로고    scopus 로고
    • Current treatments of the anxiety disorders in adults
    • Baljenger JC. Current treatments of the anxiety disorders in adults. Biol Psychiatry 1999;46:1579-1594
    • (1999) Biol Psychiatry , vol.46 , pp. 1579-1594
    • Baljenger, J.C.1
  • 18
    • 0031900040 scopus 로고    scopus 로고
    • A meta-analysis of eight randomized, double-blind, control ep clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety
    • Fawcell J, Barkin RL. A meta-analysis of eight randomized, double-blind, control ep clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. J Clin Psychiatry 1998;59:127
    • (1998) J Clin Psychiatry , vol.59 , pp. 127
    • Fawcell, J.1    Barkin, R.L.2
  • 19
    • 0031029632 scopus 로고    scopus 로고
    • Mirtazapine: An antidepressant with noradrenefgic. and serotonergic effects
    • Stinime KGL, Donheidede JA, Stahl SM. Mirtazapine: an antidepressant with noradrenefgic. and serotonergic effects. Pharmacotherapy 1997; 17:10-21
    • (1997) Pharmacotherapy , vol.17 , pp. 10-21
    • Stinime, K.G.L.1    Donheidede, J.A.2    Stahl, S.M.3
  • 20
    • 0028919350 scopus 로고
    • Focus on nefazodone: A serotonergic drug for major depression
    • Dopheide JA, Stilruner DD. Focus on nefazodone: a serotonergic drug for major depression: Formulary 1995;30:205-210, 212
    • (1995) Formulary , vol.30 , pp. 205-210
    • Dopheide, J.A.1    Stilruner, D.D.2
  • 21
    • 0034044185 scopus 로고    scopus 로고
    • Efficacy of extended-release venlafaxine in nondepressed outpatigats iiyith generalized anxiety disorder
    • Rickels K, Pollack MH, Sheehtn-bv, -et al. Efficacy of extended-release venlafaxine in nondepressed outpatigats iiyith generalized anxiety disorder. Am J Psychiatry 2000; 157:968-97
    • (2000) Am J Psychiatry , vol.157 , pp. 968-997
    • Rickels, K.1    Pollack, M.H.2    Sheehtn-bv3
  • 22
    • 0032869591 scopus 로고
    • Efficacy, safety, and tolerability of venlafaxine extended release and buspiijohe in outpatients with generalized anxiety disorder
    • Davidson JRT, DuPont RL, Hedges D.et al\Efficacy, safety, and tolerability of venlafaxine extended release and buspiijohe in outpatients with generalized anxiety disorder. J Clin Psychiatry 1960:528-535
    • (1960) J Clin Psychiatry , pp. 528-535
    • Davidson, J.R.T.1    Dupont, R.L.2    Hedges, D.3
  • 23
    • 52849106652 scopus 로고    scopus 로고
    • VentafaxinieXXR is effective for the short- And long-term treatment of generalzed anxiety disorder [poster]
    • Hamburg, Germany
    • Haskins JT, Rudolph R, Aguiar L, et al. VentafaxinieXXR is effective for the short- and long-term treatment of generalzed anxiety disorder [poster]. Presented at the 11th World Congress of Psychiatry; Aug 6-11, 1999; Hamburg, Germany 4.
    • (1999) Presented at the 11th World Congress of Psychiatry; Aug 6-11 , pp. 4
    • Haskins, J.T.1    Rudolph, R.2    Aguiar, L.3
  • 24
    • 4243416162 scopus 로고    scopus 로고
    • Dose-response efficacy of long-term treatment of venlafaxine extended-release in generalized anxiety disorder [abstract]
    • Hackett D, Desmet A, Saunas EO. Dose-response efficacy of long-term treatment of venlafaxine extended-release in generalized anxiety disorder [abstract]. Eur Neuropsychopharmacol 1999;9(suppl 5):S315
    • (1999) Eur Neuropsychopharmacol , vol.9 , Issue.5 SUPPL.
    • Hackett, D.1    Desmet, A.2    Saunas, E.O.3
  • 25
    • 0242588732 scopus 로고    scopus 로고
    • Venlafaxine XR is an efficacious short- And long-term treatment for generalized anxiety disorder
    • Oct 31-Nov 4, Paris, France
    • Haskins JT, Rudolph R, Aguiar L, et al, for the Venlafaxine XR 218 Study Group. Venlafaxine XR is an efficacious short- and long-term treatment for generalized anxiety disorder. Presented at the 11 th annual congress of the European College of Neuropsychopharmacology; Oct 31-Nov 4, 1998; Paris, France
    • (1998) 11 Th Annual Congress of the European College of Neuropsychopharmacology
    • Haskins, J.T.1    Rudolph, R.2    Aguiar, L.3
  • 26
    • 0006822948 scopus 로고    scopus 로고
    • Dose-response efficacy of venlafaxine XR in GAD [poster]
    • Aug 6-11, Hamburg, Germany
    • Hackett D, Desmet A, Saunas EO. Dose-response efficacy of venlafaxine XR in GAD [poster]. Presented at the 11th World Congress of Psychiatry; Aug 6-11, 1999; Hamburg, Germany
    • (1999) 11th World Congress of Psychiatry
    • Hackett, D.1    Desmet, A.2    Saunas, E.O.3
  • 27
    • 0029555176 scopus 로고
    • Venlafaxine in social phobia
    • Kelsey JE. Venlafaxine in social phobia. Psychopharmacol Bull 1995;31: 767-771
    • (1995) Psychopharmacol Bull , vol.31 , pp. 767-771
    • Kelsey, J.E.1
  • 28
    • 0029099365 scopus 로고
    • Venlafaxine treatment of panic disorder: A case series
    • Geracioti TD Jr. Venlafaxine treatment of panic disorder: a case series. J Clin Psychiatry 1995;56:408-410
    • (1995) J Clin Psychiatry , vol.56 , pp. 408-410
    • Geracioti Jr., T.D.1
  • 29
    • 0030074946 scopus 로고    scopus 로고
    • Open treatment of obsessivecompulsive disorder with venlafaxine: A series of ten cases [letter]
    • Rauch SL, OSullivan RL, Jenike MA. Open treatment of obsessivecompulsive disorder with venlafaxine: a series of ten cases [letter]. J Clin Psychopharmacol 1996;16:81-84
    • (1996) J Clin Psychopharmacol , vol.16 , pp. 81-84
    • Rauch, S.L.1    Osullivan, R.L.2    Jenike, M.A.3
  • 30
    • 0031963340 scopus 로고    scopus 로고
    • The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: A dose-response study
    • Khan A, Upton GV, Rudolph RL, et al. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. J Clin Psychopharmacol 1998;18:19-25
    • (1998) J Clin Psychopharmacol , vol.18 , pp. 19-25
    • Khan, A.1    Upton, G.V.2    Rudolph, R.L.3
  • 31
    • 0031909995 scopus 로고    scopus 로고
    • Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients
    • Feighner JP, Entsuah AR, McPherson MK. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients. J Affect Disord 1998;47:55-62
    • (1998) J Affect Disord , vol.47 , pp. 55-62
    • Feighner, J.P.1    Entsuah, A.R.2    McPherson, M.K.3
  • 32
    • 0029951845 scopus 로고    scopus 로고
    • Drug-drug interactions involving antidepressants: Focus on venlafaxine
    • Ereshefsky L. Drug-drug interactions involving antidepressants: focus on venlafaxine. J Clin Psychopharmacol 1996;16(3, suppl 2):37S-53S
    • (1996) J Clin Psychopharmacol , vol.16 , Issue.3 SUPPL. 2
    • Ereshefsky, L.1
  • 33
    • 80053070250 scopus 로고
    • The etiologic featiftes-of depression in adults
    • Council on Scientific Affairs, American Medical Association. The etiologic featiftes-of depression in adults. Arch Earn Med 1993;2:76-84
    • (1993) Arch Earn Med , vol.2 , pp. 76-84
  • 34
    • 0030456961 scopus 로고    scopus 로고
    • Recognizing and treating the patient with somatic manifestations of depression?
    • De WesterJN. Recognizing and treating the patient with somatic manifestations of depression? J Earn Pract 1996;43(suppl 6):S3-S15
    • (1996) J Earn Pract , vol.43 , Issue.6 SUPPL.
    • De Wester, J.N.1
  • 35
    • 0027510643 scopus 로고
    • The de facto US mental and addictive disorders service system: Epidemiologie Catchment Area prospective 1-year prevalence rate of disorders and services
    • Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system: Epidemiologie Catchment Area prospective 1-year prevalence rate of disorders and services. Arch Gen Psychiatry 1993;50:85-94
    • (1993) Arch Gen Psychiatry , vol.50 , pp. 85-94
    • Regier, D.A.1    Narrow, W.E.2    Rae, D.S.3
  • 36
    • 84943210661 scopus 로고
    • Common mental disorders and disability across cultures: Results from the WHO Collaborative Study on Psychological Problems in General Care
    • Ormel J, VonKorff M, Ustun TB et al. Common mental disorders and disability across cultures: results from the WHO Collaborative Study on Psychological Problems in General Care. JAMA 1994;272: 1741-1748
    • (1994) JAMA , vol.272 , pp. 1741-1748
    • Ormel, J.1    Vonkorff, M.2    Ustun, T.B.3
  • 37
    • 0028308789 scopus 로고
    • The prevalence and distribution of major depression in a national comjnuflitjl sample: The National Comorbidity Survey
    • Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national comjnuflitjl sample: the National Comorbidity Survey. Am J Psychiatry 1994;15:l
    • (1994) Am J Psychiatry , vol.15
    • Blazer, D.G.1    Kessler, R.C.2    McGonagle, K.A.3
  • 38
    • 52849127657 scopus 로고
    • The major depression: Cross-national comparisons
    • Cross-National Collaborative Group. The major depression: cross-national comparisons. JAMA 1992;258:309-131
    • (1992) JAMA , vol.258 , pp. 309-1131
  • 39
    • 0028597871 scopus 로고
    • Therapeutic considerations in treating depression in the elderly
    • Dunner DL. Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry 1994;55( 12, suppl):48-58
    • (1994) J Clin Psychiatry , vol.55 , Issue.12 SUPPL. , pp. 48-58
    • Dunner, D.L.1
  • 40
    • 0028607973 scopus 로고
    • Recognition and treatment of depressiort-in a prirfiafy care setting
    • Montano CB. Recognition and treatment of depressiort-in a prirfiafy care setting. J Clin Psychiatry 1994;55(12, suppl): 18-34
    • (1994) J Clin Psychiatry , vol.55 , Issue.12 SUPPL. , pp. 18-34
    • Montano, C.B.1
  • 42
    • 0031033949 scopus 로고    scopus 로고
    • Rational drug use in the treatment of depression
    • Cohen LJ. Rational drug use in the treatment of depression. PharmacQ/i therapy 1997;17:45-61
    • (1997) PharmacQ/i Therapy , vol.17 , pp. 45-61
    • Cohen, L.J.1
  • 43
    • 0028918951 scopus 로고
    • Health care costs associated with depressive and anxiety disorders in primary care
    • Simon G, Ormel J, VonKorff M, et al. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 1995; 152:352-357
    • (1995) Am J Psychiatry , vol.152 , pp. 352-357
    • Simon, G.1    Ormel, J.2    Vonkorff, M.3
  • 44
    • 0028149443 scopus 로고
    • Antidepressant drugs
    • Frazer A. Antidepressant drugs. Depression 1994;2:1-19
    • (1994) Depression , vol.2 , pp. 1-19
    • Frazer, A.1
  • 45
    • 0028272935 scopus 로고
    • Use of minor tranquilizers and antidepressant medications by depressed outpatients: Results from the Medical Outcomes Study
    • Wells KB, Katon W Rogers B, et al. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. Am J Psychiatry 1994;151:694-700
    • (1994) Am J Psychiatry , vol.151 , pp. 694-700
    • Wells, K.B.1    Katon, W.2    Rogers, B.3
  • 46
    • 0028560322 scopus 로고
    • Guidelines for the long-term treatment of depression
    • Hirschfeld RMA. Guidelines for the long-term treatment of depression. J Clin Psychiatry 1994;55(12, suppl):61-69
    • (1994) J Clin Psychiatry , vol.55 , Issue.12 SUPPL. , pp. 61-69
    • Hirschfeld, R.M.A.1
  • 47
    • 0027406598 scopus 로고
    • Comparison of full-dose versus halfdose pharmacotherapy in the maintenance treatment of recurrent depression
    • Frank E, Kupfer DJ, Perel JM, et al. Comparison of full-dose versus halfdose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 1993;27:139-145
    • (1993) J Affect Disord , vol.27 , pp. 139-145
    • Frank, E.1    Kupfer, D.J.2    Perel, J.M.3
  • 48
    • 0030727889 scopus 로고    scopus 로고
    • Citalopram: A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
    • Noble S, Benfield P. Citalopram: a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs 1997; 8:410-431
    • (1997) CNS Drugs , vol.8 , pp. 410-431
    • Noble, S.1    Benfield, P.2
  • 49
    • 52849113667 scopus 로고    scopus 로고
    • Central nervous system drugs
    • St. Louis, Mo: Facts and Comparisons
    • Central nervous system drugs. In: Drug Facts and Comparisons, 1999 ed. St. Louis, Mo: Facts and Comparisons; 1998:1603
    • (1998) Drug Facts and Comparisons, 1999 Ed. , pp. 1603
  • 50
    • 0022448068 scopus 로고
    • Citalopram: Clinical effect pro-file in comparison with clomipramine: a controlled multicenter study
    • Danish University Antidepressant Group. Citalopram: clinical effect pro-file in comparison with clomipramine: a controlled multicenter study. Psychopharmacology 1986;90:131-138
    • (1986) Psychopharmacology , vol.90 , pp. 131-138
  • 51
    • 0025217229 scopus 로고
    • Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study
    • Danish University Antidepressant Group. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990; 18:289-299
    • (1990) J Affect Disord , vol.18 , pp. 289-299
  • 52
    • 0029891688 scopus 로고    scopus 로고
    • Dose-response relationship with venlafaxine
    • Kelsey JE. Dose-response relationship with venlafaxine. J Clin Psychopharmacol 1996;16(suppl 2):21S-28S
    • (1996) J Clin Psychopharmacol , vol.16 , Issue.2 SUPPL.
    • Kelsey, J.E.1
  • 53
    • 0028075556 scopus 로고
    • The role of venlafaxine in rational antidepressant therapy
    • Feighner JP. The role of venlafaxine in rational antidepressant therapy. J Clin Psychiatry 1994;55(9, suppl A):62-70
    • (1994) J Clin Psychiatry , vol.55 , Issue.9 SUPPL. A , pp. 62-70
    • Feighner, J.P.1
  • 54
    • 0028855974 scopus 로고
    • Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia
    • Guelfi JD, White C, Hackett D, et al. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J Clin Psychiatry 1995;56:450-458
    • (1995) J Clin Psychiatry , vol.56 , pp. 450-458
    • Guelfi, J.D.1    White, C.2    Hackett, D.3
  • 55
    • 0030014201 scopus 로고    scopus 로고
    • Antidepressant options: Venlafaxine in perspective
    • Thase ME. Antidepressant options: venlafaxine in perspective. J Clin Psychopharmacol 1996;16(3, suppl 2):10S-20S
    • (1996) J Clin Psychopharmacol , vol.16 , Issue.3 SUPPL. 2
    • Thase, M.E.1
  • 56
    • 0031916752 scopus 로고    scopus 로고
    • Drug interactions: Friend or foe?
    • Jefferson JW. Drug interactions: friend or foe? J Clin Psychiatry 1998;59 (suppl 4):37-4T7
    • (1998) J Clin Psychiatry , vol.59 , Issue.4 SUPPL.
    • Jefferson, J.W.1
  • 57
    • 4243547562 scopus 로고    scopus 로고
    • Depressive disorders
    • DiPiro JT, Talbert RE, Yee GC, et al, eds. Stamford, Conn: Appleton & Eange;
    • Wells BG, Mandos EA. Depressive disorders. In: DiPiro JT, Talbert RE, Yee GC, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. Stamford, Conn: Appleton & Eange; 1997:1395-1417
    • (1997) Pharmacotherapy: A Pathophysiologic Approach , pp. 1395-1417
    • Wells, B.G.1    Mandos, E.A.2
  • 58
    • 0029829648 scopus 로고    scopus 로고
    • Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders
    • Brown C, Schulberg HC, Madonia MJ, et al. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996;153:1293-1300
    • (1996) Am J Psychiatry , vol.153 , pp. 1293-1300
    • Brown, C.1    Schulberg, H.C.2    Madonia, M.J.3
  • 59
    • 0015385801 scopus 로고
    • The prognosis of affective disorders: The differentiation of anxiety states from depressive illnesses
    • Schapira K, Roth M, Kerr TA, et al. The prognosis of affective disorders: the differentiation of anxiety states from depressive illnesses. Br J Psychiatry 1972;121:175-181
    • (1972) Br J Psychiatry , vol.121 , pp. 175-181
    • Schapira, K.1    Roth, M.2    Kerr, T.A.3
  • 60
    • 0032697699 scopus 로고    scopus 로고
    • Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys
    • Kessler RC, DuPont RE, Berglund P, et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 1999;156:1915-1923
    • (1999) Am J Psychiatry , vol.156 , pp. 1915-1923
    • Kessler, R.C.1    Dupont, R.E.2    Berglund, P.3
  • 61
    • 0030434199 scopus 로고    scopus 로고
    • Comorbid depression and anxiety spectrum disorders
    • Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety 1996;4:160-168
    • (1996) Depress Anxiety , vol.4 , pp. 160-168
    • Gorman, J.M.1
  • 62
    • 0030469377 scopus 로고    scopus 로고
    • Treating comorbid depression and anxiety
    • Kuzel RJ. Treating comorbid depression and anxiety. J Earn Pract 1996;43 (6, suppl):S45-S53
    • (1996) J Earn Pract , vol.43 , Issue.6 SUPPL.
    • Kuzel, R.J.1
  • 63
    • 0029162334 scopus 로고
    • Anxiety symptom relief in depression treatment outcomes
    • Keller MB, Hanks DE. Anxiety symptom relief in depression treatment outcomes. J Clin Psychiatry 1995;56(suppl 6):22-29
    • (1995) J Clin Psychiatry , vol.56 , Issue.6 SUPPL. , pp. 22-29
    • Keller, M.B.1    Hanks, D.E.2
  • 64
    • 0031724183 scopus 로고    scopus 로고
    • A controlled prospective, 1-year trial of citalopram in the treatment of panic disorder
    • Eepola UM, Wade AG, Eeinonen EV, et al. A controlled prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry 1998;59:528-534
    • (1998) J Clin Psychiatry , vol.59 , pp. 528-534
    • Eepola, U.M.1    Wade, A.G.2    Eeinonen, E.V.3
  • 65
    • 0030724916 scopus 로고    scopus 로고
    • Citalopram in the treatment of obsessive-compulsive disorder: An open pilot study
    • Kojjsnen H, Eepola U, Eeinonen E, et al. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study. Acta Psychiatr Scand 1997,96:343-346
    • (1997) Acta Psychiatr Scand , vol.96 , pp. 343-346
    • Kojjsnen, H.1    Eepola, U.2    Eeinonen, E.3
  • 66
    • 0030480395 scopus 로고    scopus 로고
    • Venlafaxine for panic disorder: Results from a double-blind, placebo-controlled study
    • 66: Pollack fptE.Worthington JJ III, Otto MW, et al. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull S96;32:667-670
    • (1996) Psychopharmacol Bull , vol.32 , pp. 667-670
    • Pollack, E.1    Worthington III, J.J.2    Otto, M.W.3
  • 67
    • 0030470480 scopus 로고    scopus 로고
    • An open trial of nefazodone in adult patients with generalized anxiety disorder
    • Hedges.-D;-4, Rennljerr FW, Strong RE, et al. An open trial of nefazodone in adult patients with generalized anxiety disorder. Psychopharmacol Bull 1996;32:671-676.
    • (1996) Psychopharmacol Bull , vol.32 , pp. 671-676
    • Hedges, D.1    Rennljerr, F.W.2    Strong, R.E.3
  • 68
    • 0028800848 scopus 로고
    • Efficacy and tolerability of serotonin transport inhibito obsessive-compulsive disorder: A metaanalysis
    • Greist JH, Jeffer Son JW Obak KA, et al. Efficacy and tolerability of serotonin transport inhibito obsessive-compulsive disorder: a metaanalysis. Arch Gen Psychiatry 995;52;53-60
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 53-60
    • Greist, J.H.1    Jeffer Son, J.W.2    Obak, K.A.3
  • 69
    • 0030988949 scopus 로고    scopus 로고
    • Antidepressants in panisfajsorder
    • Jefferson JW. Antidepressants in panisfajsorder. J Clin Psychiatry 1997;58 (suppl 2):20-25
    • (1997) J Clin Psychiatry , vol.58 , Issue.2 SUPPL. , pp. 20-25
    • Jefferson, J.W.1
  • 70
    • 9544233539 scopus 로고    scopus 로고
    • Chronological milestones to guide drug change: When should clinicians.switch antidepressants?
    • Quitkin FM, McGrath PJ, Stewart JW, Chronological milestones to guide drug change: when should clinicians.switch antidepressants? Arch Gen Psychiatry 1996;53:785-792
    • (1996) Arch Gen Psychiatry , vol.53 , pp. 785-792
    • Quitkin, F.M.1    McGrath, P.J.2    Stewart, J.W.3
  • 71
    • 0029948564 scopus 로고    scopus 로고
    • Clinical evaluation of venlafaxine
    • Ballenger JC. Clinical evaluation of venlafaxine.jj ClinPsychopharmacol 1996;16(suppl 2):29S-36S
    • (1996) Jj ClinPsychopharmacol , vol.16 , Issue.2 SUPPL.
    • Ballenger, J.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.